Search Results - "Perez Martinez, Ariadna"

P1264: A PREDEFINED STRATEGY AIMED TO REDUCE ANTIBIOTIC EXPOSURE OF SCT RECIPIENTS PRESERVES DIVERSITY AND COMPOSITION OF INTESTINAL MICROBIOTA AND REDUCES THE INCIDENCE OF ACUTE‐GVHD WITHOUT SIDE EFFECTS by Espigado, Ildefonso, Rodríguez‐Torres, Nancy, Jimenez‐Jorge, Silvia, Yáñez Sansegundo, Lucrecia, Vázquez López, Lourdes, Solano, Carlos, Kwon, MI, Aguilar‐Guisado, Manuela, Fernández‐Luis, Sara, Avendaño Pita, Alejandro, Perez‐Martinez, Ariadna, Bailén, Rebeca, Labrador Herrera, Gema, Domínguez‐Velasco, Nazaret, Torre‐Corona, Laura, José Márquez‐Malaver, Francisco, Limón Ramos, Carmen, Cerrillo Matilla, Julio, María Rosso‐Fernández, Clara, Alba, Claudio, Antonio Pérez‐Simón, Jose, Ibáñez, María Eugenia Pachón

Get full text

Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high‐risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real‐world comparison by Tormo, Mar, Pérez‐Martínez, Ariadna, Calabuig, Marisa, Hernández‐Boluda, Juan Carlos, Amat, Paula, Navarro, David, Solano, Carlos

“…Summary This is an observational‐retrospective study comparing the real‐world outcomes associated with posaconazole vs itraconazole as prophylaxis treatments…”
Get full text

REAL-WORLD EXPERIENCE OF ISAVUCONAZOLE IN ALLOGENEIC STEM CELL TRANSPLANTATION IN SPAIN by Kwon, Mi, Gómez-Centurión, Ignacio, Oarbeascoa, Gillen, Torres, Melissa, Martinez, Ariadna Perez, Suarez-Lledó, Maria, Chinea, Anabelle, Cascón, Maria Jesus Pascual, Vazquez, Lourdes, Espigado, Ildefonso, Izquierdo, Isabel, Parody, Rocio, Cadenas, Irene Garcia, Calbacho, Maria, Sierra, Pedro Gonzalez, Heras, Inmaculada, Yañez, Lucrecia, Torrent, Anna, Bautista, Guiomar, Gonzalez, Soledad, Roldan, Elisa, Vallejo, Juan Carlos, Bailen, Rebeca, Borrero, Asunción, Lopez-Jiménez, Javier, Casas, Maria Angeles Cuesta, Solano, Carlos

“…Invasive fungal infections (IFI) pose a significant complication after hematopoietic stem cell transplantation (HSCT). Isavuconazole (ISV) is a new generation…”
Get full text

Prognostic Impact of the New CLL-IPI Index in a Single Center CLL Spanish Cohort by Ferrer Lores, Blanca, Navarro Cubells, Blanca, Serrano Alcala, Alicia, Castillo Martin, Ivan, Teruel Casasus, Anabel, Ballester Martinez, Sandra, Perez Martinez, Ariadna, Mauricio Campos, Ana, Castillo Valero, Inmaculada, Cano Gracia, Horacio, Solano Vercet, Carlos, Terol Casterá, María José

“…The hallmark for Chroniclymphocytic leukemia (CLL) is a highly variable clinical course. An international prognostic index (CLL-IPI) is a promising tool to…”
Get full text

Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in Spain by Kwon, Mi, Gómez-Centurión, Ignacio, Oarbeascoa, Gillen, Torres, Melissa, Martinez, Ariadna Perez, Suarez-Lledó, Maria, Chinea, Anabelle, Cascón, Maria Jesus Pascual, Vazquez, Lourdes, Espigado, Ildefonso, Izquierdo, Isabel, Parody, Rocio, Cadenas, Irene Garcia, Calbacho, Maria, Sierra, Pedro Gonzalez, Heras, Inmaculada, Yañez, Lucrecia, Torrent, Anna, Bautista, Guiomar, Gonzalez, Soledad, Roldan, Elisa, Vallejo, Juan Carlos, Bailen, Rebeca, Borrero, Asunción, Lopez-Jiménez, Javier, Casas, Maria Angeles Cuesta, Solano, Carlos

“…•Invasive fungal infections (IFI) remain a significant complication in allogeneic stem cell transplantation (allo-HSCT) recipients, with a reported incidence…”
Get full text

Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies by Fox, Maria Laura, García-Cadenas, Irene, Navarro, Victor, Martínez, Ariadna Pérez, Kara, Meriem, Bazán, Irene Sánchez, Ferra Coll, Christelle, Bailén, Rebeca, Bento, Leyre, Parody, Rocío, Esquirol, Albert, Ortí, Guillermo, Mussetti, Alberto, Salamero, Olga, Martino, Rodrigo, González, Ana Pérez, Barba, Pere, Kwon, Mi, Solano, Carlos, Bosch, Francesc, Valcárcel, David

“…Despite novel cellular and immunomodulatory therapies, allogeneic hematopoietic stem cell transplantation (HSCT) remains a treatment option for lymphoid…”
Get full text

The Presence Of 1 / 8 HLA Mismatch Do Not Hamper Survival After Allogeneic Stem Cell Transplantation Using Immunoprophylaxis With Sirolimus-Tacrolimus by Parody, Rocío, López-Corral, Lucía, Godino, Oriana Lopez, Cadenas, Irene García, Lourdes, Vazquez, Martino, Rodrigo, Martinez, Carmen, Solano, Carlos, Martinez, Ariadna Perez, Barba, Pere, Valcarcel, David, Falantes, Jose F., Márquez-Malaver, Francisco J, Caballero, Dolores, Perez-Simón, Jose Antonio

“…Several studies from the IBMTR have shown that overall survival (OS) is reduced by 10% for each mismatched at obligatory locus (A,B,C or DRB1) after allogeneic…”
Get full text

Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis by Fox, María Laura, García-Cadenas, Irene, Pérez, Ariadna Martínez, Villacampa, Guillermo, Piñana, José Luis, Ortí, Guillermo, Montoro, Juan, Roldán, Elisa, Bosch Vilaseca, Anna, Martino, Rodrigo, Salamero, Olga, Saavedra, Silvana, Hernandez-Boluda, Juan Carlos, Esquirol, Albert, Sierra, Jordi, Sanz, Jaime, Solano, Carlos, Bosch, Francesc, Barba, Pere, Valcarcel, David

“…In classical reduced-intensity conditioning (RIC) regimens, including the fludarabine and busulphan (BF) combination, sirolimus and tacrolimus (SIR-TAC) as…”
Get full text

Haploidentical Donor Vs. Mismatch Unrelated Donor in Reduced Intensity Conditioning Transplant: A Study from the Spanish Group of Hematopoietic Transplant and Cell Therapy (GETH-TC) by Fox, María Laura, Cabirta, Alba, Pérez Martínez, Ariadna, Esquirol, Albert, Fonseca, Marta, Navarro Garcés, Víctor, Heras, Inmaculada, Bento, Leyre, Calo Pérez, Aida, Zudaire, Teresa, Calbacho, Maria, Gago, Beatriz, Pérez, Ana, Ortí, Guillermo, García-Cadenas, Irene, Corral, Lucía López, Navarro-Fernández, José, Montoro Gomez, Juan, Sampol, Antonia, Solano, Carlos, Valcarcel, David

Get full text

Salvage Treatment with Novel Agents Is Preferable to Standard Chemotherapy in Patients with Large B-Cell Lymphoma Progressing after Chimeric Antigen Receptor T-Cell Therapy by Iacoboni, Gloria, Iraola-Truchuelo, Josu, Mussetti, Alberto, Fernández-Caldas, Paula, Navarro Garcés, Víctor, Martin Lopez, ANA Africa, Delgado, Javier, Pérez Martínez, Ariadna, Guerreiro, Manuel, Caballero Gonzalez, Ana Carolina Carolina, Martínez-Cibrián, Nuria, Luzardo Henriquez, Hugo Daniel, Sanchez, Jose M., Sancho, Juan-Manuel, Barba, Pere, Kwon, Mi, Corral, Lucía López, Hernani, Rafael, Reguera, Juan Luis, Sureda, Anna, Martín García-Sancho, Alejandro, Bastos-Oreiro, Mariana, Abrisqueta, Pau

Get full text

Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience from the Spanish Group of Hematopoietic Transplant (GETH-TC) by Bailen, Rebeca, Vicario, Jose Luis, Herruzo, Beatriz, Guerra, Luisa Maria, Vallés, Ana, Esquirol, Albert, Fonseca, Marta, Solán, Laura, Sanchez Vadillo, Irene, Bento, Leyre, Pérez Martínez, Ariadna, Torrent, Anna, Zanabili, Joud, Calbacho, Maria, Alenda, Raquel, Moreno, Miguel Ángel, Gago, Beatriz, Chinea, Anabelle, García-Cadenas, Irene, Boix-Giner, Francisco, López Lorenzo, José Luis, Humala, Karem, Acosta-Fleitas, Cynthia, Sampol, Antonia, Oarbeascoa, Gillen, Anguita, Javier, Diez-Martin, Jose L., Kwon, Mi

“…Background. Donor specific antibodies (DSAs) are preformed IgG antibodies with specificity against HLA molecules not shared with the donor that can lead to…”
Get full text

Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy by Bailén, Rebeca, Alenda, Raquel, Herruzo-Delgado, Beatriz, Acosta-Fleitas, Cynthia, Vallés, Ana, Esquirol, Albert, Fonseca, Marta, Solán, Laura, Sánchez-Vadillo, Irene, Bautista, Guiomar, Bento, Leyre, López-Godino, Oriana, Pérez-Martínez, Ariadna, Torrent, Anna, Zanabili, Joud, Calbacho, María, Moreno, Miguel Ángel, Pascual-Cascón, María Jesús, Guerra-Domínguez, Luisa, Chinea, Anabelle, García-Cadenas, Irene, López-Corral, Lucía, Boix-Giner, Francisco, López Lorenzo, José Luis, Humala, Karem, Duarte, Rafael, Sampol, Antonia, Heras, Inmaculada, Vicario, José Luis, Balas, Antonio, Oarbeascoa, Gillen, Fernández-Caldas, Paula, Anguita, Javier, Kwon, Mi

“…Donor-specific antibodies (DSAs) are IgG allo-antibodies against mismatched donor HLA molecules and can cause graft failure (GF) in the setting of…”
Get full text

Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Lymphomas: Improved Results Overtime by Novelli, Silvana, Bento, Leyre, García-Cadenas, Irene, Prieto, Laura, Corral, Lucía López, Gutierrez Garcia, Gonzalo, Hernani, Rafael, Pérez Martínez, Ariadna, Sierra, Jorge, Solano, Carlos, Bastos-Oreiro, Mariana, Dorado, Nieves, Rodríguez-Torres, Nancy, Rodríguez, Guillermo, Piñana Sanchez, Jose Luis, Montoro Gómez, Juan, Herrera Puente, Pilar, Luna, Alejandro, Sanchez Ortega, Isabel, Martin Calvo, Carmen, López-Godino, Oriana, Heras, Inmaculada, Zanabili, Joud, Palomo Moraleda, María Del Pilar, Parody, Rocio, Moraleda, Jose Maria, Yáñez, Lucrecia, Gutiérrez, Antonio, Zudaire, Teresa, Cordoba, Raul, Varela, Rosario, Ferra, Christelle M, Martinez-Lopez, Joaquin, García-Torres, Estefania, Caballero, Dolores

“…Allogeneic hematopoietic stem cell transplantation (alloSCT) is the only curative strategy for relapsed/refractory T cell lymphoma (T-NHL). In the past ten…”
Get full text

Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Study on Behalf of the Spanish Hematopoietic Stem Cell Transplantation and Cellular Therapy Group (GETH) by Gómez-Centurión, Ignacio, Gallardo Morillo, Ana Isabel, Pérez Martínez, Ariadna, Cabrero Calvo, Mónica, Chinea, Anabelle, González, Leslie, Pedraza, Alexandra, Jiménez Lorenzo, María Josefa, Robles, María Calbacho, Bailén, Rebeca, Cascón, María Jesús Pascual, Cabero, Almudena, Piñana Sánchez, José Luis, Luna, Alejandro, Perera Alvarez, Mar, Rovira, Montserrat, Torrent Catarineu, Anna, Sánchez-Pina, José, Kwon, Mi

“…•This study describes characteristics of patients with SOS/VOD after haplo-HSCT with PT-Cy.•Among the 797 haplo-HSCT recipients, 46 patients (5.77%) were…”
Get full text

Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study by Escamilla Gomez, Virginia, García Gutiérrez, Valentín, Caballero-Velázquez, Teresa, Rodríguez-Torres, Nancy, Espigado, Ildefonso, Corral, Lucia Lopez, Caballero, Dolores, García-Cadenas, Irene, Martino, Rodrigo, Saavedra Gerosa, Silvanna Daniela, Pérez Martínez, Ariadna, González Sierra, Pedro Antonio, Viguria Alegria, Maria De La Cruz, Zudaire, Teresa, Parra Salinas, Ingrid Magnolia, Poch, Marc, González Vincent, Marta, Díaz Pérez, Miguel Ángel, Molina Angulo, Blanca, Sanchez-Ortega, Isabel, Parody Porras, Rocio, Ferra Coll, Christelle M, Orti, Guillermo, Valcarcel, David, De La Camara, Rafael, Molés, Paula, Sanz, Jaime, Montoro Gómez, Juan, Velázquez-Kennedy, Kyra, Pérez-Simón, José A.

“…1. INTRODUCTION Graft-versus-host disease (GVHD) is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT)…”
Get full text

Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study by Jiménez-Jorge, Silvia, Labrador-Herrera, Gema, Rosso-Fernández, Clara M, Rodríguez-Torres, Nancy, Pachón-Ibáñez, María Eugenia, Smani, Younes, Márquez-Malaver, Francisco José, Limón Ramos, Carmen, Solano, Carlos, Vázquez-López, Lourdes, Kwon, Mi, Mora Barrios, Joan Manuel, Aguilar-Guisado, Manuela, Espigado, Ildefonso

“…IntroductionHaematopoietic stem cell transplantation (HSCT) is a life-saving treatment for a number of haematological diseases. Graft versus host disease…”
Get full text